Gf Fund Management Co. Ltd. Biomarin Pharmaceutical Inc Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 4,880 shares of BMRN stock, worth $283,576. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,880
Previous 4,002
21.94%
Holding current value
$283,576
Previous $263 Million
31.14%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BMRN
# of Institutions
668Shares Held
184MCall Options Held
1.24MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.32 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.1 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$1.03 Billion1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$869 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$628 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.8B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...